The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poe, J. C.
Right arrow Articles by Tedder, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poe, J. C.
Right arrow Articles by Tedder, T. F.
The Journal of Immunology, 2004, 172: 2100-2110.
Copyright © 2004 by The American Association of Immunologists

Severely Impaired B Lymphocyte Proliferation, Survival, and Induction of the c-Myc:Cullin 1 Ubiquitin Ligase Pathway Resulting from CD22 Deficiency on the C57BL/6 Genetic Background 1

Jonathan C. Poe, Karen M. Haas, Junji Uchida, Youngkyun Lee, Manabu Fujimoto2 and Thomas F. Tedder3

Department of Immunology, Duke University Medical Center, Durham, NC 27710

Understanding the molecular mechanisms through which CD22 regulates B lymphocyte homeostasis, signal transduction, and tolerance is critical to defining normal B cell function and understanding the role of CD22 in autoimmunity. Therefore, CD22 function was examined in vivo and in vitro using B cells from CD22-deficient (CD22-/-) mice. Backcrossing of founder CD22-/- mice onto the C57BL/6 (B6) genetic background from a B6/129 mixed background resulted in a dramatically reduced B cell proliferative response following IgM ligation, characterized by a paucity of lymphoblasts and augmented apoptosis. Also, the phenotype of splenic B6 CD22-/- B cells was uniquely HSAhigh and IgDlow/CD21low with intermediate levels of CD5 expression, although the percentages of mature and transitional B cells were normal. That B6 CD22-/- B cells predominantly underwent apoptosis following IgM ligation correlated with this unique tolerant phenotype, as well as defective induction of the c-Myc:Cullin 1 (CUL1) ubiquitin ligase pathway that is necessary for progression to the S phase of cell cycle. CD40 ligation compensated for CD22 deficiency by restoring lymphoblast development, proliferation, c-Myc and CUL1 expression, and protein ubiquitination/degradation in IgM-stimulated B6 CD22-/- B cell cultures. Thereby, this study expands our current understanding of the complex role of CD22 during B cell homeostasis and Ag responsiveness, and reveals that the impact of CD22 deficiency is dictated by the genetic background on which it is rendered. Moreover, this study defines CD22 and CD40 as the first examples of lymphocyte coreceptors that influence induction of the c-Myc:CUL1 ubiquitin ligase pathway.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. M. Haas, S. Sen, I. G. Sanford, A. S. Miller, J. C. Poe, and T. F. Tedder
CD22 Ligand Binding Regulates Normal and Malignant B Lymphocyte Survival In Vivo.
J. Immunol., September 1, 2006; 177(5): 3063 - 3073.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Fujimoto, Y. Kuwano, R. Watanabe, N. Asashima, H. Nakashima, S. Yoshitake, H. Okochi, K. Tamaki, J. C. Poe, T. F. Tedder, et al.
B Cell Antigen Receptor and CD40 Differentially Regulate CD22 Tyrosine Phosphorylation
J. Immunol., January 15, 2006; 176(2): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Varki and T. Angata
Siglecs--the major subfamily of I-type lectins
Glycobiology, January 1, 2006; 16(1): 1R - 27R.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. M. Harnett
CD40: A Growing Cytoplasmic Tale
Sci. Signal., June 15, 2004; 2004(237): pe25 - pe25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.